This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $21,266.51 and a period of performance through August 14, 2024. It is a firm-fixed price contract, and there is no set-aside designation. AmerisourceBergen holds a large Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,713.24 and is a firm fixed-price delivery order with a completion date of May 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The delivery order has a ceiling value of $11,945.58 and a completion date of September 6, 2024. This order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL sizes, which are used to treat type 2 diabetes. The contract has a firm fixed price of $8,559.48 and a period of performance ending on September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The total ceiling value of the contract is $13,119.44, with a completion date of December 30, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $6,295.60 and a completion date of August 9, 2024. This award is a firm fixed-price delivery order and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and there...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (0.25-0.5 mg/dose pen, 3 mL), a medication used for the treatment of diabetes. The contract has a ceiling value of $3,678.12 and a completion date of April 13, 2023. It is a firm-fixed-price contract, and there was no set-aside designation used.
AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The contract has a ceiling value of $3,284.73 and a period of performance through December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The delivery order, valued at $1,741.62, is a firm fixed-price contract with a completion date of August 26, 2024. It is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for the treatment of type 2 diabetes. The contract has a firm fixed price of $4,933.08 and a completion date of November 1, 2024. The contract was not set aside for any particular business type. AmerisourceBergen holds a significant...